BioSpace News Archive

Sofinnova Partners announced today it has led Inventiva Pharma (IVA) €35,5 M capital increase through its newly created Sofinnova Crossover I Fund.

Royal Philips is showcasing its integrated radiation oncology solutions in the exhibition at the European Society for Radiation Oncology’s (ESTRO) 37th Annual Meeting in Barcelona, Spain.

On 26 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2018.

Moberg Pharma AB announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with the company part-time as Senior Adviser.

Helperby also presented preclinical data which shows that AZT is active against carbapenem and colistin resistant Enterobacteriaceae. AZT is a DNA chain terminator and represents a new class of antibacterial agent against the most resistant Gram-negative bacteria. Further data were presented showing the combination to be active in animal models.

OBI Pharma, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase I/II study of OBI-3424, a first-in-class DNA alkylating agent that targets cancers that overexpress the aldo-keto reductase 1C3 (AKR1C3) enzyme.

As part of its annual visit to Capitol Hill, the American Academy of Ophthalmology is speaking on behalf of millions of American patients who need timely access to treatments and care for a range of diseases affecting the eyes.

DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced the release of its 2017 Community Care report, which highlights key clinical, operational and corporate social responsibility (CSR) achievements in the past year.

mscripts announced several key features aimed at providing patients with price transparency and the ability to pay for prescriptions through their mobile phones.

RealSelf, Inc. announced it has raised $40 million in its first financing round since 2008.